Skip to content

A real-world evidence, open-label, retrospective study exploring the clinical accuracy, satisfaction and safety of the Nucleus® SmartNav system in patients with CochlearTM Nucleus® implants

A real-world evidence, open-label, retrospective study exploring the clinical accuracy, satisfaction and safety of the Nucleus® SmartNav system in patients with CochlearTM Nucleus® implants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117501
Enrollment
Unknown
Registered
2026-01-26
Start date
2026-01-26
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sensorineural hearing loss

Interventions

The observation group of sensorineural hearing loss:None

Sponsors

Shulan (Boao) Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 12 months or above (at the time of surgery) 2. Willing and able to follow the research plan. 3. Willing and able to provide a written informed consent form. 4. The surgery will take place from January 26, 2025 to the period when this real-world study begins. 5. This retrospective study will only include implanters who have undergone post-operative imaging examinations. 6. This retrospective study will only include implanters whose intraoperative examination results have been saved in the Nucleus SmartNav software.

Exclusion criteria

Exclusion criteria: 1. There may be ossification, otosclerosis, deformity or any other cochlear abnormalities (such as a common cavity) that could prevent the complete implantation of the electrode array in the target ear. 2. The target ear has previously undergone cochlear implant surgery. 3. Unrealistic expectations regarding the potential benefits, risks and limitations of participating in this study are determined by the researchers. 4. Any contraindications for cochlear implantation as listed in the relevant product doctor's guidelines. 5. Other defects that may affect the subject's participation in the study or safety during the clinical research. 6. Unable or unwilling to comply with the clinical research requirements determined by the researchers. 7. Center staff directly related to this study and/or their immediate family members; immediate family members refer to spouse, parents, children or siblings. 8. Employees of Cochlear or employees of the contract research organization or contractor hired by Cochlear for this study purpose, determined by the researchers. 9. Currently participating or having participated in another interventional clinical study/ trial involving investigational drugs or devices within the past 30 days.

Design outcomes

Primary

MeasureTime frame
Accuracy of system location check;

Secondary

MeasureTime frame
The occurrence of adverse events and device defects;

Countries

China

Contacts

Public ContactSun Yuefeng

Shulan (Boao) Hospital

yfengsun@163.com+86 138 6817 4688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026